Extracellular Vesicles in Sickle Cell Disease: A Promising Tool - Université des Antilles Access content directly
Journal Articles Bioengineering Year : 2022

Extracellular Vesicles in Sickle Cell Disease: A Promising Tool


Sickle cell disease (SCD) is the most common hemoglobinopathy worldwide. It is characterized by an impairment of shear stress-mediated vasodilation, a pro-coagulant, and a pro-adhesive state orchestrated among others by the depletion of the vasodilator nitric oxide, by the increased phosphatidylserine exposure and tissue factor expression, and by the increased interactions of erythrocytes with endothelial cells that mediate the overexpression of adhesion molecules such as VCAM-1, respectively. Extracellular vesicles (EVs) have been shown to be novel actors involved in SCD pathophysiological processes. Medium-sized EVs, also called microparticles, which exhibit increased plasma levels in this pathology, were shown to induce the activation of endothelial cells, thereby increasing neutrophil adhesion, a key process potentially leading to the main complication associated with SCD, vaso-occlusive crises (VOCs). Small-sized EVs, also named exosomes, which have also been reported to be overrepresented in SCD, were shown to potentiate interactions between erythrocytes and platelets, and to trigger endothelial monolayer disruption, two processes also known to favor the occurrence of VOCs. In this review we provide an overview of the current knowledge about EVs concentration and role in SCD.
Fichier principal
Vignette du fichier
manuscript.v9 FINAL.pdf (1.14 Mo) Télécharger le fichier
Origin Publisher files allowed on an open archive

Dates and versions

hal-03819493 , version 1 (18-10-2022)



Yann Lamarre, Elie Nader, Philippe Connes, Marc Romana, Yohann Garnier. Extracellular Vesicles in Sickle Cell Disease: A Promising Tool. Bioengineering, 2022, 9 (9), pp.439. ⟨10.3390/bioengineering9090439⟩. ⟨hal-03819493⟩
34 View
95 Download



Gmail Mastodon Facebook X LinkedIn More